Zhao-Jun Wang Selected Research

Amyloid Plaque

10/2018	Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
1/2018	Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhao-Jun Wang Research Topics

Disease

17	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 03/2015
9	Cognitive Dysfunction 04/2024 - 01/2020
4	Memory Disorders (Memory Loss) 04/2023 - 01/2016
4	Type 2 Diabetes Mellitus (MODY) 04/2017 - 06/2016
3	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 01/2017
3	Osteoarthritis 01/2019 - 10/2016
2	Epilepsy (Aura) 03/2024 - 01/2022
2	Amyloid Plaque 10/2018 - 01/2018
1	Zoonoses 04/2024
1	Glucose Metabolism Disorders 12/2023
1	Vascular Remodeling 05/2023
1	Circadian Rhythm Sleep Disorders (Delayed Sleep Phase Syndrome) 04/2023
1	Anxiety Disorders (Anxiety Disorder) 04/2023
1	Atrial Fibrillation 01/2023
1	Hepatolenticular Degeneration (Wilson's Disease) 08/2022
1	ST Elevation Myocardial Infarction 01/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Clonorchiasis 01/2022
1	Digestive System Diseases 01/2022
1	Glioma (Gliomas) 01/2022
1	Infections 01/2022
1	COVID-19 01/2022
1	Neoplasms (Cancer) 01/2022
1	Seizures (Absence Seizure) 01/2022
1	Wounds and Injuries (Trauma) 01/2020
1	Chronobiology Disorders (Circadian Rhythm Disorder) 01/2020
1	Iron Deficiencies 09/2019
1	Iron Overload 09/2019
1	Parkinson Disease (Parkinson's Disease) 10/2018
1	Neuroinflammatory Diseases 01/2018
1	Cardiomyopathies (Cardiomyopathy) 09/2017
1	Hemorrhage 01/2017

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 09/2022 - 01/2006
10	Amyloid (Amyloid Fibrils)IBA 04/2024 - 03/2015
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023 - 01/2017
3	OrexinsIBA 04/2024 - 01/2020
3	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 03/2024 - 01/2022
3	Advanced Glycation End ProductsIBA 01/2019 - 10/2016
2	Orexin ReceptorsIBA 04/2024 - 01/2023
2	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 06/2016
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2006
2	Peptides (Polypeptides)IBA 10/2018 - 03/2015
2	Insulin (Novolin)FDA Link 01/2017 - 06/2016
1	hydroxide ionIBA 04/2024
1	Sirtuin 1IBA 12/2023
1	semaglutideIBA 12/2023
1	Ketone BodiesIBA 10/2023
1	Competitive Endogenous RNAIBA 08/2023
1	Long Noncoding RNAIBA 08/2023
1	Melatonin Receptors (Melatonin Receptor)IBA 04/2023
1	Serotonin (5 Hydroxytryptamine)IBA 04/2023
1	Dopamine (Intropin)FDA LinkGeneric 04/2023
1	agomelatine (S20098)IBA 04/2023
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2023
1	1- (2- methylbenzoxazol- 6- yl)- 3- (1,5)naphthyridin- 4- yl ureaIBA 01/2023
1	AntralIBA 01/2023
1	OxyntomodulinIBA 09/2022
1	Amyloid beta-PeptidesIBA 09/2022
1	Penicillamine (Cuprimine)FDA Link 08/2022
1	CytokinesIBA 01/2022
1	ferric chlorideIBA 01/2022
1	EnzymesIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Immunoglobulin E (IgE)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	ferrostatin-1IBA 01/2022
1	trichostatin A (A 300)IBA 01/2021
1	AlbuminsIBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	SynaptophysinIBA 01/2021
1	TensinsIBA 01/2021
1	Calcium Release Activated Calcium ChannelsIBA 01/2020
1	suvorexantIBA 01/2020
1	cadherin 5IBA 01/2020
1	Orexin Receptor AntagonistsIBA 01/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020
1	Actins (F Actin)IBA 01/2020
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	Ferritins (Ferritin)IBA 09/2019
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 01/2019
1	xestospongin CIBA 01/2019
1	SynucleinsIBA 10/2018
1	lixisenatideIBA 01/2018
1	Neuroprotective AgentsIBA 04/2017
1	davunetideIBA 01/2017
1	CJC 1131IBA 01/2017
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2017
1	Local AnestheticsIBA 01/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 06/2016
1	TeaIBA 04/2015
1	AntioxidantsIBA 04/2015

Therapy/Procedure

1	Oral Administration 04/2024
1	Therapeutics 05/2023
1	Catheter Ablation 01/2023
1	Drug Therapy (Chemotherapy) 01/2022
1	Percutaneous Coronary Intervention 01/2022
1	Immunotherapy 01/2022
1	Cardiac Resynchronization Therapy 09/2017